Health Bulletin 27/April/2022 Dr. Nandita Mohan27 April 2022 4:58 PM ISTHere are the top health stories for the day :NMC denies permission to 3 Medical Colleges, 550 MBBS seats lostFinding major deficiencies in three major...
GSK launches single inhaler-triple therapy Trelegy Ellipta to treat COPD in India Ruchika Sharma27 April 2022 11:53 AM ISTTrelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated...
Coronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age group of children MD Bureau26 April 2022 5:00 PM ISTDCGI approved restricted use for emergency situation to ZycovD for children above the age of 12 years for a two-dose regimen.
SII Covovax gets DCGI emergency use nod for 12 to 18 year olds Ruchika Sharma24 March 2022 12:09 PM ISTCovovax is the fourth vaccine to receive EUA from DCGI for use among adolescents 12 and older.
Bharat Biotech's intranasal booster vaccine may be potential game changer, say expert MD Bureau13 March 2022 12:25 PM ISTThe clinical trials for phase three of the BBV154 vaccine developed by the Hyderabad-based firm started at the All India Institute of Medical Sciences...
Biological E seeks EUA for Corbevax for children MD Bureau10 March 2022 5:39 PM ISTCorbevax is India's first indigenously developed Receptor Binding Domain (RBD) Protein sub-unit vaccine against Covid-19.
Kriya Medical Technologies bags DCGI license for RT-PCR kit KRIVIDA Novus Ruchika Sharma15 Feb 2022 12:42 PM ISTNew Delhi: Medical devices firm Kriya Medical Technologies has recently received manufacturing licence from the DCGI (Drugs Controller General of...
DCGI regular market nod to Covaxin, Covishield for adults Ruchika Sharma28 Jan 2022 12:06 PM ISTNew Delhi: India's drug regulator Drugs Controller General of India's (DCGI) on Thursday granted regular market approval for Covid-19 vaccines...
MSN to launch generic anti-COVID pill Molnupiravir Medical Dialogues Bureau8 Jan 2022 9:45 AM ISTNew Delhi: Pharmaceuticals firm MSN Group on Thursday said it will launch its generic anti-COVID-19 pill Molnupiravir under the brand 'Molulow' in...
No painkillers or paracetamol recommended after Covaxin jab: Bharat Biotech Medical Dialogues Bureau6 Jan 2022 12:03 PM ISTNew Delhi: Bharat Biotech on Wednesday said no painkillers or paracetamol are recommended after being vaccinated with its COVID-19 vaccine...
Biological E seeks DCGI nod for phase-3 trial of Corbevax as booster dose Ruchika Sharma13 Oct 2021 11:41 AM ISTNew Delhi: Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial...
Reliance Life Sciences gets DCGI approval for COVID vaccine trial Ruchika Sharma4 Sept 2021 1:36 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Friday granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct...
